Eupraxia Pharmaceuticals Inc.
Eupraxia Pharmaceuticals Inc. (EPRX.TO) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · EPRX.TO · as of Jun 8, 2026
Key Statistics
Explore Eupraxia Pharmaceuticals Inc. Data
eprx.to stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 2 · Buy rate: 100.0%
Competitors & Peers
eprx.to competitorsEPRX.TO
CYBN.NE
DR.TO
FRX.TO
HBP.TO
MDNA.TOStock Performance
Full HistoryAbout Eupraxia Pharmaceuticals Inc.
Eupraxia Pharmaceuticals Inc. a clinical stage biotechnology company, engages in the discovery, development, and marketing of technologies in the biotechnology sector. The company's lead product cand…
what is eupraxia pharmaceuticals inc. · eprx.to stock overview · eupraxia pharmaceuticals inc. company profile · who is eupraxia pharmaceuticals inc. ceo · eprx.to TSX · eupraxia pharmaceuticals inc. headquarters · eupraxia pharmaceuticals inc. business segments
About Stock Overview & Key Data
Eupraxia Pharmaceuticals Inc. (EPRX.TO) is a Healthcare company in the Biotechnology industry, listed on TSX since Mar 9, 2021. As of the latest trading session, EPRX.TO stock price is $8.33, with a market capitalization of $299.4M. The stock has returned +52.84% over the past 12 months and -19.28% year-to-date.
According to 2 Wall Street analysts, the consensus rating for Eupraxia Pharmaceuticals Inc. stock is Buy, with an average 12-month price target of $—. In fiscal year 2025, Eupraxia Pharmaceuticals Inc. reported revenue of — and net income of -$39.3M. For detailed data — including Eupraxia Pharmaceuticals Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Eupraxia Pharmaceuticals Inc. (EPRX.TO) stock price is $8.33. The stock is traded on TSX under the ticker symbol EPRX.TO. The 52-week range is $5.20 – $12.86.